Cargando…

Genetic alteration profiling of patients with resected squamous cell lung carcinomas

In this study, we analyzed the genetic profiles of squamous cell lung carcinoma (SqCLC) to identify potential therapeutic targets. Approximately 2,800 COSMIC mutations from 50 genes were determined by next-generation sequencing. Amplification/deletion of SOX2, CDKN2A, PTEN, FGFR1, EGFR, CCND1, HER2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tao, Dan, Han, Xiaohong, Zhang, Ningning, Lin, Dongmei, Wu, Di, Zhu, Xinxin, Song, Wenya, Shi, Yuankai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095023/ https://www.ncbi.nlm.nih.gov/pubmed/27145277 http://dx.doi.org/10.18632/oncotarget.9096

Ejemplares similares

Antitumor activity of histone deacetylase inhibitor chidamide alone or in combination with epidermal growth factor receptor tyrosine kinase inhibitor icotinib in NSCLC
por: Zhang, Ningning, et al.
Publicado: (2019)

Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma
por: Han, Xiaohong, et al.
Publicado: (2019)

Effectors of Epidermal Growth Factor Receptor Pathway: The Genetic Profiling of KRAS, BRAF, PIK3CA, NRAS Mutations in Colorectal Cancer Characteristics and Personalized Medicine
por: Shen, Yinchen, et al.
Publicado: (2013)

DLX2 Is a Potential Immune-Related Prognostic Indicator Associated with Remodeling of Tumor Microenvironment in Lung Squamous Cell Carcinoma: An Integrated Bioinformatical Analysis
por: Huang, Liling, et al.
Publicado: (2022)

High‐throughput and multi‐phases identification of autoantibodies in diagnosing early‐stage breast cancer and subtypes
por: Luo, Rongrong, et al.
Publicado: (2021)

Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?
por: Friedlaender, Alex, et al.
Publicado: (2019)

Neoadjuvant PD‐1 inhibitor combines with chemotherapy versus neoadjuvant chemotherapy in resectable squamous cell carcinoma of the lung
por: Feng, Yuan, et al.
Publicado: (2021)

Mutational signatures and chromosome alteration profiles of squamous cell carcinomas of the vulva
por: Han, Mi-Ryung, et al.
Publicado: (2018)

Mutational and Transcriptional Characterization Establishes Prognostic Models for Resectable Lung Squamous Cell Carcinoma
por: Liu, Yinqiang, et al.
Publicado: (2023)

LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma
por: Liu, Bing, et al.
Publicado: (2016)

Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma
por: Cai, Lei, et al.
Publicado: (2021)

Segmentectomy or Wedge Resection in Stage IA Lung Squamous Cell Carcinoma and Adenocarcinoma?
por: Li, Guoshu, et al.
Publicado: (2021)

Simultaneous videothoracoscopic resection for thymoma and lung squamous cell carcinoma, and review of the literature
por: Sayan, Muhammet, et al.
Publicado: (2022)

Investigation on the potential of circulating tumor DNA methylation patterns as prognostic biomarkers for lung squamous cell carcinoma
por: Liu, Yutao, et al.
Publicado: (2020)

Genetic alterations and field defect in head and neck squamous cell carcinoma
por: Strzelczyk, J K, et al.
Publicado: (2012)

Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays
por: Kenmotsu, Hirotsugu, et al.
Publicado: (2014)

Genetic Alteration Profiles and Clinicopathological Associations in Atypical Parathyroid Adenoma
por: Mao, Xinxin, et al.
Publicado: (2021)

Transformation of Lung Squamous Cell Carcinoma to Small Cell Lung Cancer After Immunotherapy Resistance: A Case Report
por: Wang, Diming, et al.
Publicado: (2023)

Somatic genome alterations in relation to age in lung squamous cell carcinoma
por: Meucci, Stefano, et al.
Publicado: (2018)

ALK‐rearranged squamous cell carcinoma of the lung
por: Meng, Qiyi, et al.
Publicado: (2021)

LGI1 encephalitis with squamous lung-cell carcinoma: Resolution after tumor resection
por: Virupakshaiah, Akash, et al.
Publicado: (2020)

Endoscopic Resection of Hypopharyngeal Squamous Cell Carcinoma
por: Bok, Gene Hyun, et al.
Publicado: (2013)

Profile of Nivolumab in the Treatment of Resected Esophageal Squamous Cell Carcinoma: A Review of the Clinical Data
por: Kim, Yuntae, et al.
Publicado: (2023)

Role of downregulated ADARB1 in lung squamous cell carcinoma
por: Wang, Xiang, et al.
Publicado: (2020)

Arsenic-related DNA copy-number alterations in lung squamous cell carcinomas
por: Martinez, V D, et al.
Publicado: (2010)

Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
por: Campbell, Joshua D., et al.
Publicado: (2016)

Neoadjuvant pembrolizumab with chemotherapy for the treatment of stage IIB–IIIB resectable lung squamous cell carcinoma
por: Shen, Dijian, et al.
Publicado: (2021)

Prognostic Significance of the Lung Immune Prognostic Index in Patients with Resected Esophageal Squamous Cell Carcinoma
por: Feng, Ji-Feng, et al.
Publicado: (2021)

ER expression associates with poor prognosis in male lung squamous carcinoma after radical resection
por: Yang, Xue, et al.
Publicado: (2021)

Development of Paraneoplastic Neuromyelitis Optica after Lung Resection in a Patient with Squamous Cell Carcinoma
por: Eba, Shunsuke, et al.
Publicado: (2021)

Patient-derived tumor xenografts of lung squamous cell carcinoma alter long non-coding RNA profile but not responsiveness to cisplatin
por: Lu, Dapeng, et al.
Publicado: (2018)

Tracking longitudinal genetic changes of circulating tumor DNA (ctDNA) in advanced Lung adenocarcinoma treated with chemotherapy
por: Han, Xiaohong, et al.
Publicado: (2019)

Profiling of lung microbiota discloses differences in adenocarcinoma and squamous cell carcinoma
por: Gomes, Sílvia, et al.
Publicado: (2019)

The changing landscape of anti-lung cancer drug clinical trials in mainland China from 2005 to 2020
por: Zhong, Qiaofeng, et al.
Publicado: (2021)

The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing
por: Wang, Chengdi, et al.
Publicado: (2022)

Epigenetic and Genetic Alterations Affect the WWOX Gene in Head and Neck Squamous Cell Carcinoma
por: Ekizoglu, Seda, et al.
Publicado: (2015)

Surgical Options for Resectable Lung Adenosquamous Carcinoma: A Propensity Score-Matched Analysis
por: Zhu, Shuncang, et al.
Publicado: (2022)

Liver resection and ablation for squamous cell carcinoma liver metastases
por: Engstrand, J, et al.
Publicado: (2021)

Alterations in serum protein glycopatterns related to small cell lung cancer, adenocarcinoma and squamous carcinoma of the lung
por: Jia, Liyuan, et al.
Publicado: (2020)

Utilization of circulating cell-free DNA profiling to guide first-line chemotherapy in advanced lung squamous cell carcinoma
por: Jiang, Tao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7v8tn8hh083eshsnao9cr76025